Reach the 3 Million Find, Treat, Cure TB BASIC CONTENTS OF RNTCP WEBSITE OF THE DIRECTORATE OF HEALTH SERVICES, ODISHA
|
|
- Brittany Harmon
- 6 years ago
- Views:
Transcription
1 BASIC CONTENTS OF RNTCP WEBSITE OF THE DIRECTORATE OF HEALTH SERVICES, ODISHA About us The National Tuberculosis Control Programme (NTP) was implemented in Orissa in the year 1964 with the objective to provide free and domiciliary treatment to the patients detected through passive case finding method. The NTP did not achieve the desired success as a result the programme was revised with the DOTS (Directly Observed Treatment Short Course Chemotherapy) strategy and implemented in our State in the year 1997 with the objective to detect 70% of infectious sputum positive TB cases and cure at least 85% of them. The programme is implemented as per the Technical, Operational and Financial guidelines of Revised National TB Control Programme (RNTCP). The RNTCP was assisted by Danida through Government of India from 1996 to The Global Fund to fight AIDS, TB and Malaria (GFATM) provides financial and technical support to implement the programme in the State from the year 2006 to 2010 through Government of India. The Rolling Continuation Channel (RCC) project of GFATM has been extended till the year The Government of India releases necessary funds to the Director of Health Services, Orissa through the Orissa State Health & Family Welfare Society on the basis of the Statement of Expenditure, Audit report and Annual Action Plan. Govt. of India also provides 100% requirement of anti TB drugs for treatment under RNTCP. The Lepra-India, an international NGO, is also providing support under Axshaya project to IEC-BCC activities in 12 districts of Orissa (Angul, Bhubaneswar, Cuttack, Gajapati, Ganjam, Koraput, Kandhamal, Malkangiri, Mayurbhanj, Puri, Sambalpur and Sundargarh) The Catholic Bishop Conference of India (CBCI) and the Indian Medical Association (IMA) are also involved in RNTCP of the State. Organogram: State TB Officer at Health Directorate, Odisha. District TB Officer at all District Head Quarters & Capital Hospital, Bhubaneswar. Designated Medical Officer at Sub-district (Block level) TB Unit (MO-TU) Medical Officer at Designated Microscopy Centre DOTS Centre
2 Activity Sr. No. RNTCP Performance of Odisha State at a glance (Key indicators) 2014 (Jan - Dec 2014) Indicator Norm Achievement % 1 Population covered (in lacs) % of PHIs referring more than 2% of new Adult OPD for sputum examination 1,976 37% 3 TB Suspects examined per lac population/qtr > Sputum Smear Positive Patients diagnosed 8-12 % 27,966 12% Sputum Smear Positive Patients living in the district and put on DOTS New Sputum Smear Positive Patients put on treatment Annualised New Sputum Smear Positive detection rate per Lac > 95% 23,383 91% >60 /lac/yr and >70% 20, % 8 Total TB Cases put on treatment 9 Annualised Total Case Detection Rate per Lac 230 / lac 45, % of new EP cases out of all new cases 10-15% 24% % of retreatment cases out of all smear positive cases % of new smear positive out of total new pulmonary cases 3 Months Sputum Conversion of New Smear Positive cases registered in the last Quarter Cure Rate of New Sputum Positive Cases registered in corresponding quarter of last year Success Rate of New Sputum Positive Patients registered in corresponding quarter of last year 20-40% 16% 45-70% >90% out of out of % 88% out of >85% % out of >85% %
3 Contacts IMPORTANT CONTACT NUMBERS - RNTCP - ODISHA Sl. No Name Designation ID Mobile Office Dr. (Mrs) Sanjukta Sahoo Dr. Sachidananda Mishra Dr. P.G. DasMahapatra Joint Director TB-cum-STO stoor@rntcp.org Asst. Program Officer cum Epidemiologist stoor@rntcp.org TB HIV Coordinator stoor@rntcp.org MO, State TB Dr. Laxmidhar Pradhan Cell stoor@rntcp.org Phone Name of ATD&TC Officials Designation ID Mobile (Office) Superintendent Dr. Sanjit Pattanaik ATD&TC stdcor@rntcp.org Dr. Gautam Patnaik MO ATD&TC stdcor@rntcp.org Dr. Paresh Nath Mohanty Microbiologist, stdcor@rntcp.org; ATD&TC pareshmohanty67@gmail.com Phone Name of WHO Consultant Region ID Mobile (Office) Dr. Sandeep Kindo Dr. Rajendra Narayan Panigrahi Dr. Balakrishna Panda Western Odisha KindoS@rntcp.org HQ, Odisha PanigrahiR@rntcp.org Southern Odisha pandab@rntcp.org
4 Programmes / Schemes Reach the 3 Million Present Status Since inception of RNTCP in 1997 till 2014, total 6,03,103 TB cases have been detected and treated. Total 4,71,687 cases have been cured & successfully completed treatment and 28,062 cases reported died. Out of the said reported death cases all deaths may not be due to TB. It includes death due to other causes also. In the year 2014, the annualized new sputum positive case detection rate of Orissa was 55% against the norm of 70% and the success rate 86% as against the norm of 85%. The programme is implemented though 31 implementing units, 159 TB Units and 549 Microscopy centers. 48,993 DOT Centres are functioning under the programme to provide DOTS to the registered TB patients. The programme has the following major activities. o DOTS for CAT-I & CAT-II patients o PMDT (Programmatic Management of Drug Resistant TB) for CAT-IV & CAT-V patients (for MDR & XDR TB patients respectively) o Intensified TB-HIV activities to ensure 100% testing for HIV of all diagnosed TB cases & treatment of co-infected patients. o Entry of data in NIKSHAY portal of RNTCP of all diagnosed TB patients. o Notification of all diagnosed and treated TB patients is mandatory for all Laboratories, Private Practitioner and Hospitals. o Medical college involvement Presently 6 out of 7 including AIIMS Bhubaneswar are involved in the program for diagnosis and treatment of TB patients in the Medical colleges The Anti TB Demonstration & Training Centre (ATD&TC) Cuttack is functioning as a training center of RNTCP and conducts External Quality Assessment (EQA) to maintain good quality sputum microscopy. Intermediate Reference laboratory (IRL) at Anti TB Demonstration & Training Centre, Cuttack accredited on 10th Aug 2009 conducting solid culture, Liquid Culture for Culture & DST of M Tb & Line Probe Assay (LPA). It is matter of pride for the State that Regional Medical Research Centre, Bhubaneswar has been declared as a new National Reference laboratory for the Eastern and North Eastern region of India. It has been accredited for culture and Drug Susceptibility Test for solid culture, supporting for follow up cultures from 7 districts (Koraput, Nabarangpur, Kalahandi, Rayagada, Gajapati, Kandhamal & Malkangiri). NRL RMRC Bhubaneswar is also supporting Diagnostic samples of MDR suspects from districts of Nabarangapur, Kalahandi, Rayagada, Gajapati, Malakngiri. PMDT (Programmatic Management of Drug Resistant TB Cases) rolled out in the entire state. Till 3Q14, out of the sputum samples of 5499 Drug Resistant TB (DR-TB) suspects examined, 700 patients have been diagnosed as Drug Registrant TB and out of them 613 patients (88%) have been initiated on treatment since the year 2009 till In addition 21 nos. of XDR TB patients have been detected under RNTCP. All drugs and diagnostics are provided free of cost.
5 Reach the 3 Million Diagnosed DR-TB patients can now be admitted in the existing DR TB wards at SCB, VSS & MKCG Medical College. TB and HIV collaborative services have been strengthened in all districts with the state progressively increasing the proportion of TB patients tested for HIV. The TB HIV Intensive Package is implemented in all the districts since 2010 in collaboration with the OSACS. During the year 2014 out of total registered TB patients, (68.4%) are examined and 628 found TB-HIV co-infected. To further improve TB surveillance in both Private and Public sectors in India, NIKSHAY a real time, online notification, recording and reporting system has been implemented in the state with most of the districts entering data for all the patients registered in Till date 72,541 patients from Govt. Sector have been entered in the Nikshay portal. Block level MIS-Coordinators along with STS play an important role to ensure 100% entry in this portal. TB Notification which has been made mandatory as per GoI notification has been initiated and reporting of TB patients from private Sector started. Our partner Indian Medical Association (IMA), Odisha is fully supporting our efforts. Till date (4Q14) 1111 TB patients had been notified and registered from Private sector in NIKSHAY. The State Task Force (STF) mechanism for the involvement of all Medical Colleges in RNTCP is operational, headed by DMET as STF Chairperson. As such three Govt Medical Colleges of our State and SUM Medical College & Hospital Bhubaneswar have received one LED Microscope each for diagnosis of TB cases. The State has organized National Task Force (NTF) Workshop in the month of March 2014 and Zonal Task Force (ZTF) meeting on January 2015 in Bhubaneswar for active involvement of Medical colleges in RNTCP. State has optimally rolled out Tribal action plan in 11 notified tribal districts catering to 22.47% of tribal population of the State. To further improve TB surveillance in both Private and Public sectors in India, Nikshay a real time, online notification, recording and reporting system has been implemented in the state with most of the districts entering data for all the patients registered in Till date 72,541 patients from Govt. Sector have been entered in the Nikshay portal. School awareness programmes, Patient Provider interaction meeting, PRI Sensitization, Street Play & Folk Dance are conducted at district level to create awareness for early diagnosis and treatment of TB. In addition Swasthya Kantha in all villages is being utilized to disseminate TB messages to the community The programme is also supported by Partners like Axshaya GF-TB Project in 12 districts, Indian Medical Association and Catholic Bishop Conference of India (CBCI) and Red Cross India.
6 Notifications TB has been declared a notifiable disease by the Govt of India and subsequently by the Govt. of Odisha on Advertisements To be updated whenever there is an advertisement. RTI Act Link For any information regarding TB and its control including recent developments in the filed of diagnosis & treatment and achievements of different States etc, the National website of RNTCP can be accessed at News & Updates World TB Day is observed on 24 th March every year to commemorate discovery of TB bacillus by Robert Koch, a German Scientist, in the year This discovery led to inventions of appropriate medications to fight TB. Indian Medical Association (IMA) has made TB notification mandatory and published the said notification in a separate Resolution. The 4 th DR TB Centre has been established at DHH Koraput to diagnose DR TB using CBNAAT (Cartridge Based Nucleic Acid Amplification Test) technique. Archive Section - With administration of DOTS a TB patient has been cured and could be able to lead a happy life and earn his livelihood.
7 - Poster to use DOTS more widely: Reach the 3 Million
8 - Declaration of IMA regarding mandatory notification of TB:
9 - Declaration of Govt. of Odisha regarding notification of TB on :
10 - Govt. of India ban on use of Serodiagnostic kit to diagnose TB:
11 Photo Gallery (RNTCP reviewed by the Secretry Health & FW Odisha) (ASHAs of Baliguda Sub Divison Promising for their active Involvment in TB Case Detection and Cure) (Children Participation in TB Awareness) (TB Awareness Rath) Download Forms (Administering DOTS by ASHA) All forms, modules of RNTCP can be downloaded from the National website
Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor
Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Global scenario*: Burden of TB Incidence : 9.6 million (58% SEAR and Western Pacific) Deaths : 1.5 million
More informationMalaria: Bringing Down The Burden In Odisha. Dr. MM Pradhan Dy. Director, NVBDCP, Odisha
Malaria: Bringing Down The Burden In Odisha Dr. MM Pradhan Dy. Director, NVBDCP, Odisha MMV Stakeholders Meeting, Delhi (India), 8 th Nov, 212 Odisha at a glance Area: 156, sq kms (4% of India s land area)
More informationIndia s Contribution in Rolling out Newer and Rapid Diagnostics towards PMDT Scale-up
India s Contribution in Rolling out Newer and Rapid Diagnostics towards PMDT Scale-up Balasangameshwara Vollepore, FIND (India) FIND and Partners Symposium 43 rd Union World Conference on Lung Health November
More informationRevised National Tuberculosis Control Programme
Revised National Tuberculosis Control Programme 1 OUTLINE OF PRESENTATION Introduction Burden Of The Disease Evolution Of RNTCP Goals And Objectives Of RNTCP DOTS Stop TB Strategy Organization RNTCP Endorsed
More informationRole of RNTCP in the management MDR-TB
Kamdar DJ, Shah NA, Patel DJ, Parmarr H. Role of RNTCP in the management of MDR-TB. IAIM, 2015; 2(7): 1-5. Original Research Article Role of RNTCP in the management of MDR-TB Deepali J Kamdar 1, Neha A
More informationConcern India HIV Programme
Concern India HIV Programme Background Orissa HIV Scenario HIV prevalence in general population is 0.22% Ganjam is the 2 nd high prevalent district in India (prevalence rate is 3.25%) 16,733 persons identified
More informationPROJECT AXSHYA COMMUNITY ENGAGEMENT in TB CARE
PROJECT AXSHYA COMMUNITY ENGAGEMENT in TB CARE An NGO-consortium initiative by World Vision India & Partners 4 th Dec 15 CSOs TB Project supported by The GFATM Round 9 grant PR: World Vision India SRs:
More informationApplication of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes
Application of the Onion model to assess the extent of missing tuberculosis cases by the National Programmes Dr Amal Bassili Stop TB unit, WHO, Regional Office for the Eastern Mediterranean Surveillance
More informationTUBERCULOSIS CONTROL SAARC REGION
TUBERCULOSIS CONTROL SAARC REGION UPDATE 2009 SAARC Tuberculosis & HIV/AIDS Centre (STAC) (Thimi, Bhaktapur), P. O. Box No. 9517, Kathmandu, Nepal. Tel: 6631048, 6632477, 6632601 Fax: 00977-1-6634379 E-mail:
More informationPerformance of RNTCP NTI Bulletin 2005,41/3&4,
Performance of RNTCP NTI Bulletin 2005,41/3&4, 118-122 A Cohort Analysis of Performance of RNTCP in MS Subramanya Rao*, KP Unnikrishnan**, MA Sharada BACKGROUND Tuberculosis (TB) is one of the most serious
More informationGENDER DISPARITY ODISHA, Directorate of Economics and Statistics, Odisha, Bhubaneswar
GENDER DISPARITY ODISHA, 2010 Directorate of Economics and Statistics, Odisha, Bhubaneswar 4 GENDER DISPARITY ODISHA, 2010 Directorate of Economics and Statistics, Odisha, Bhubaneswar 5 Shri Panchanan
More informationTuberculosis Screening and IPT: Experience from India
Tuberculosis Screening and IPT: Experience from India Dr B.B.Rewari WHO National consultant Care, Support and Treatment National Programme Officer (ART) National AIDS Control Organization New Delhi-110001,
More informationOverview of the Presentation
Overview of the Presentation Definitions(TBCase, MDR-TB & XDR-TB) Global Tuberculosis (TB,HIV/TB,MDR & XDR)Scenario & Trend Risk factor for TB Natural history of TB Types of TB & Trends of Extra Pulmonary
More informationTuberculosis in the SAARC Region An Update 2007
SAARC Tuberculosis and HIV/AIDS Centre Tuberculosis in the SAARC Region An Update 27 SAARC Tuberculosis and HIV/AIDS Centre (STC) (Thimi, Bhaktapur) P. O. Box No. 9517, Kathmandu, Nepal Tel: 977-1-663148,
More informationUGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance
More informationCOMMONEST CAUSE OF INITIATING CATEGORY II DIRECTLY OBSERVED TREATMENT SHORT COURSE IN TUBERCULOSIS PATIENTS
Original Research Article DOI - 10.26479/2016.0204.06 COMMONEST CAUSE OF INITIATING CATEGORY II DIRECTLY OBSERVED TREATMENT SHORT COURSE IN TUBERCULOSIS PATIENTS Manthan Mehta 1, Cherylann Melo 2, Shital
More informationImplementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation
Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB Global Consultation Geneva, 30 November 2010 Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva,
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationTB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO
TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%
More informationTB Program and Epidemic aka B2B
TB Program and Epidemic aka B2B Nulda Beyers On behalf of DTTC BOD Workshop 30 September2013 Trend in tuberculosis incidence, selected countries in Africa 1400 1200 Rate per 100,000 1000 800 600 400 200
More informationTuberculosis-HIV epidemic situation and emerging challenges in North India
NTI Bulletin 2015,51 /1&4, 1 7 Tuberculosis-HIV epidemic situation and emerging challenges in North India Rajesh Deshmukh 1,3, Raghu Ram Rao 2, Shah A 2,3, Sreenivas A Nair 3, R S Gupta 1, SD Khaparde
More informationRevised National Tuberculosis Control Programme
Revised National Tuberculosis Control Programme 2015 C e n t r a l T B D i v i s i o n D i r e c t o r a t e G e n e r a l o f H e a l t h S e r v i c e s M i n i s t r y o f H e a l t h & F a m i l y
More informationUSAID TB CARE II Bangladesh:
B ANGLADESH USAID TB CARE II Bangladesh: Grants Spotlight This document has been developed by the TB CARE II project and is made possible by the generous support of the American people through the United
More informationGuidance on Matching Funds: Tuberculosis Finding the Missing People with TB
February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each
More informationDefinitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013
Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf
More informationWHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010
WHO Task Force Framework on assessment of TB surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO consultant Nov/Dec 2010 Task Force on TB Impact Measurement Mandate To produce a robust,
More informationDelivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV.
Delivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV. Introduction: Deshmukh Rajesh 1 Ashok Kumar 1 K.S.Sachdeva 2 Amar Shah 2 India is
More informationDRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION
JOURNAL OF PREVENTIVE MEDICINE 2008; 16(3-4): 3-9 Inviting Editorial DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION Harshad Thakur Centre for Health Policy, Planning and Management,
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Short Communication First Line Drug Resistance Study in Pulmonary Tuberculosis Patients from Prakasini Satapathy 1, Bairagi
More informationMDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT
TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words
More informationChallenges in Scaling-up TB/HIV collaborative activities in a diverse HIV epidemic -India
Challenges in Scaling-up TB/HIV collaborative activities in a diverse HIV epidemic -India Dr. B. B. Rewari WHO National Consultant National Programme Officer (ART) National AIDS Control Organisation New
More informationRev Re ised Na tional TB Con Con ro r l Pr ogr ogr mme T chnic chnic l a & Oper Oper t a ional Guideline for TB Control in India March 2016
Revised National TB Control Programme Technical & Operational Guideline for TB Control in India March 2016 Why TOG and why it is required? October 2005 As per the programme developments, time to time it
More informationXpert MTB/RIF assay validation experience --- impact and plan in China
Xpert MTB/RIF assay validation experience --- impact and plan in China Dr. Zhao Yanlin Chinese Center for Disease Control & Prevention Dr. Richard O Brien FIND April. 16, 2013 Progress Contribution for
More informationWR s Speech on inaugural ceremony of Community based Programmatic Management of Drug resistance TB (CPMDT).
WR s Speech on inaugural ceremony of Community based Programmatic Management of Drug resistance TB (CPMDT). The Chief guest Prof. Dr. A.F.M. Ruhul Haque M.P Hon ble Minister, Ministry of Health and Family
More informationTuberculosis Control In The South-East Asia Region: Annual TB Report 2015 By WHO Regional Office for South-East Asia READ ONLINE
Tuberculosis Control In The South-East Asia Region: Annual TB Report 2015 By WHO Regional Office for South-East Asia READ ONLINE If you are searched for the ebook Tuberculosis Control in the South-East
More informationIMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE
Original Article IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE P. G. Gopi, R. Subramani, V. Chandrasekaran, T. Santha and P. R. Narayanan
More informationMODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit
MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative
More informationThe predominance of female deficiency has been a
a case study International Journal of Commerce and Business Management ; Vol. 4 Issue 1 (April, 2011) : 155-162 A critical analysis of sex ratio in n scenario with special reference to Orissa Received
More informationStop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan
Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB
More informationTreatment Outcome of Pulmonary and Extra Pulmonary Tuberculosis Patients in TB and Chest Disease Hospital DOT Centre, Goa, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 4 (2016) pp. 437-441 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.504.051
More informationTOG The Way Forward
TOG 2016- The Way Forward Main Changes in Diagnostic algorithm Definition (Type, Classification, Outcome) Registration at the time of Diagnosis (PHI level Notification Register) Long term follow up (till
More informationThe Three I s for HIV/TB and Rolling out IPT beyond Pilot -India
The Three I s for HIV/TB and Rolling out IPT beyond Pilot -India Dr. B. B. Rewari WHO National Consultant National Programme Officer (ART) National AIDS Control Organisation New Delhi, India 1 Content
More informationSTATUS OF RE-REGISTERED PATIENTS FOR TUBERCULOSIS TREATMENT UNDER DOTS PROGRAMME
Original Article STATUS OF RE-REGISTERED PATIENTS FOR TUBERCULOSIS TREATMENT UNDER DOTS PROGRAMME V.Chandrasekaran, P.G.Gopi, T.Santha, R.Subramani and P.R.Narayanan (Original received on 24.4.2006. Revised
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationExperience with implementation of Xpert MTB/RIF in India. Dr K S Sachdeva Addl. DDG (TB), Government of India
Experience with implementation of Xpert MTB/RIF in India Dr K S Sachdeva Addl. DDG (TB), Government of India Background Two ongoing projects being implemented in India, under RNTCP by FIND Gene Xpert feasibility
More informationInvesting for Impact
Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,
More informationNational framework for joint. TB-Diabetes. collaborative activities. Revised National Tuberculosis Control Programme (RNTCP)
National framework for joint TB-Diabetes collaborative activities Revised National Tuberculosis Control Programme (RNTCP) National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular
More informationPOSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH
POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH Akos Somoskövi, M.D., Ph.D. and Giorgio Roscigno, M.D. ANNUAL GLI MEETING, 4 th OCTOBER 2010 MERIEUX FOUNDATION, ANNECY Integrated Laboratory Network
More informationBriefing on Intensified Malaria Control Project-3 (IMCP-3)
Briefing on Intensified Malaria Control Project-3 (IMCP-3) India CCM Induction and Orientation Workshop 3 rd -4 th December 2015 Directorate of National Vector Borne Diseases Control Programme, Delhi Plan
More informationLet s Talk TB. A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year
A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Lancelot M. Pinto, MD, MSc Author Madhukar Pai, MD, PhD co-author and Series Editor Abstract Nearly 50% of patients with
More informationNational TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health
National TB Prevalence survey in Myanmar By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health 58 million pop. 676,577 sq km (75/sq km) S+ notification rate/100,000 population
More informationHow best to structure a laboratory network with new technologies
How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics
More informationTuberculosis Control. in the South-East Asia Region
2005 Tuberculosis Control in the South-East Asia Region SEA-TB-282 Tuberculosis Control in the South-East Asia Region The Regional Report: 2005 WHO Project No: ICP TUB 001 World Health Organization This
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Short Communication Awareness of Medical Interns Regarding Recent Guidelines of Revised National Tuberculosis Control
More informationMultidrug-Resistant TB
Multidrug-Resistant TB Diagnosis Treatment Linking Diagnosis and Treatment Charles L. Daley, M.D. National Jewish Health University of Colorado Denver Disclosures Chair, Data Monitoring Committee for delamanid
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationPrinciple of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos
Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases
More informationSputum grading as a predictor of treatment outcome of new sputum smear positive tuberculosis patients in Khammam Tuberculosis Unit
Sputum grading as a predictor of treatment outcome of new sputum smear positive tuberculosis patients in Khammam Tuberculosis Unit Shankar Reddy Dudala 1, Raghotham Reddy K 2, Chandrasekhar Reddy Bolla
More informationRamesh P. M.*, Saravanan M.
International Journal of Advances in Medicine Ramesh PM et al. Int J Adv Med. 2018 Jun;5(3):561-565 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20181663
More informationTUBERCULOSIS IN THE SAARC REGION AN UPDATE 2006
SAARC Tuberculosis and HIV/AIDS Centre TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2006 SAARC Tuberculosis & HIV/AIDS Centre (STC) P. O. Box No. 9517, Kathmandu, Nepal Thimi, Bhaktapur Tel: 6631048, 6632477,
More informationRajib Saha. 1. Introduction
Tuberculosis Research and Treatment Volume 2016, Article ID 8608602, 8 pages http://dx.doi.org/10.1155/2016/8608602 Research Article Predictors of Treatment Outcome for Retreatment Pulmonary Tuberculosis
More informationTUBERCULOSIS IN THE SAARC REGION AN UPDATE 2005
SAARC TB Centre TUBERCULOSIS IN THE SAARC REGION AN UPDATE 2005 SAARC Tuberculosis Centre (STC) (Thimi, Bhaktapur), P. O. Box No. 9517, Kathmandu, Nepal. Tel: 6631048, 6632477, 6632601 Fax: 00977-1-6634379
More informationNational Symposium on Universal Health Coverage in India
National Symposium on Universal Health Coverage in India Theme: Bridging the Knowledge and Implementation Gap Summary Report Organised by: KIIT School of Public Health (KSPH) Date: 12 th December, 2016
More informationRam Sharan Gopali (MPH) Executive Director
Ram Sharan Gopali (MPH) Executive Director Basic Facts of Nepal Nepal is a landlocked country located in the WHO Asian region at the edge of the Himalaya between India and the Peoples Republic of China
More informationCosting of the Sierra Leone National Strategic Plan for TB
Costing of the Sierra Leone National Strategic Plan for TB 2016-2020 Introduction The Government of Sierra Leone established the National Leprosy Control Programme in 1973 with support from the German
More informationInternational Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007
TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationCORRELATES OF DELAYED INITIATION OF TREATMENT AFTER CONFIRMED DIAGNOSIS UNDER RNTCP: A CROSS SECTIONAL STUDY IN AHMEDABAD MUNICIPAL CORPORATION, INDIA
Original Article CORRELATES OF DELAYED INITIATION OF TREATMENT AFTER CONFIRMED DIAGNOSIS UNDER RNTCP: A CROSS SECTIONAL STUDY IN AHMEDABAD MUNICIPAL CORPORATION, INDIA Financial Support: None declared
More informationTB: A Supplement to GP CLINICS
TB: A Supplement to GP CLINICS Chapter 4: Improving Access to Affordable and Quality TB Tests in India Authors: Madhukar Pai, MD, PhD Author and Series Editor Tuberculosis Tuberculosis (TB) remains one
More informationTB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai
TB/HIV 2 sides of the same coin Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai Global- Tb new cases Diagnosis-Microscopy ZN,Flourescent microscopy(fm) Rapid, inexpensive test Specificity>95%
More informationUpdate on Management of
Update on Management of DR TB Definitions Presumptive MDR-TB A patient suspected of drug-resistant TB, based on RNTCP criteria for submission of specimens for drug-susceptibility testing MDR-TB Case A
More informationXpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work
Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection Results of Group Work DOTS expansion and enhancement Objective This group deals with the majority
More informationManaging the Revised National Tuberculosis Control Programme in Your Area. A Training Course. Modules 1 4
Managing the Revised National Tuberculosis Control Programme in Your Area A Training Course Modules 1 4 1 Course Introduction 2 Ensuring Identification of Tuberculosis Suspects 3 Supporting Laboratory
More informationGuidelines on Programmatic Management of Drug Resistant TB (PMDT) in India
Revised National Tuberculosis Control Programme Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India March 2017 Central TB Division, Directorate General of Health Services, Ministry
More informationAssessing the programmatic management of drug-resistant TB
Assessing the programmatic management of drug-resistant TB a. Review the programmatic management of drug-resistant TB patients with the TB manager. i. What is the size of MDR-TB problem locally? How many
More informationAnnex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)
IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,
More informationLet s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year
Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year Lancelot M. Pinto, MD, MSc Author Madhukar Pai, MD, PhD co-author and Series Editor Lancelot Pinto is a
More informationTB/HIV Project in the Philippines. Yumiko Yanase
TB/HIV Project in the Philippines Yumiko Yanase 1 TB situation in the Philippines Global rank: 9th Incidence (all): 296 Prevalence (all): 458 TB mortality (all): 49 New MDR-TB: 3.2% Case types notified
More informationAssessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan
Assessment of the performance of TB surveillance in Kenya main findings, key recommendations and associated investment plan Accra, Ghana May 1 st 2013 Hillary K. Kipruto on behalf of the Kenya team System
More informationMinistry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)
Ministry of Health National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Contents Executive summary... 2 Background... 3 National Tuberculosis Program Overview... 3
More informationSAARC EPIDEMIOLOGICAL RESPONSE ON TUBERCULOSIS
SAARC EPIDEMIOLOGICAL RESPONSE ON TUBERCULOSIS 2017 SAARC Tuberculosis & HIV/AIDS Centre (STAC) i SAARC EPIDEMIOLOGICAL RESPONSE ON TUBERCULOSIS 2017 SAARC Tuberculosis & HIV/AIDS Centre (STAC) Thimi,
More informationSOUTH AFRICA S TB BURDEN - OVERVIEW
SOUTH AFRICA S TB BURDEN - OVERVIEW Dr Aaron Motsoaledi, MP: Chairperson of the Board, Stop TB Partnership Minister of Health, South Africa 31 January 2014, Cape Town South Africa s TB Burden Global TB
More informationTB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)
TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global
More informationA study on non-compliance in tuberculosis cases towards the directly observed treatment short course under RNTCP in Kanpur Nagar
International Journal of Community Medicine and Public Health Srivastava K et al. Int J Community Med Public Health. 2017 Dec;4(12):4485-4489 http://www.ijcmph.com pissn 2394-6032 eissn 2394-6040 Original
More informationImplementing revised TB/HIV recording and reporting tools Country Experience. Dr Nathan Kapata National TB/ Leprosy Programme Manager
Implementing revised TB/HIV recording and reporting tools Country Experience Dr Nathan Kapata National TB/ Leprosy Programme Manager Outline Objective Background Implementation of TB/HIV collaborative
More informationNEW STRATEGIES OF TB CONTROL IN INDIA : ARE WE ON THE RIGHT TRACK?
130 Editorial NEW STRATEGIES OF TB CONTROL IN INDIA : ARE WE ON THE RIGHT TRACK? [Indian J Tuberc 2012; 59: 130-134] The control of tuberculosis still remains elusive as the epidemic of tuberculosis (TB),
More informationTB Data Quality Assurance: United Kingdom
TB Data Quality Assurance: United Kingdom Ibrahim Abubakar, MBBS, PhD, FFPH Tuberculosis Section HPA Centre for Infections 8,655 cases in 2008 14.1 per 100,000 Increase over last 2 decades TB Surveillance
More informationTuberculosis Control
SEA-TB-293 Tuberculosis Control in the South-East Asia Region The Regional Report: 2006 WHO Project No: ICP TUB 001 Further publications can be obtained from: TB Unit, Department of Communicable Diseases
More informationAuthors Malhotra, S; Zodpey, S P; Chandra, S; Vashist, R P; Satyanaryana, S; Zachariah, R; Harries, A D
MSF Field Research Should Sputum Smear Examination Be Carried Out at the End of the Intensive Phase and End of Treatment in Sputum Smear Negative Pulmonary TB Patients? Authors Malhotra, S; Zodpey, S P;
More informationScale up of MDR TB Management in the Philippines: Lessons Learned
Scale up of MDR TB Management in the Philippines: Lessons Learned Tropical Disease Foundation in collaboration with the NTP, Department of Health Ma. Imelda D. Quelapio, MD Philippines: Magnitude of the
More informationIssue 9: January March, 2017 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana
Issue 9: January March, 2017 National Malaria Control Programme (NMCP) Box KB 493 Korle - Bu Accra Ghana Contents Page Editorial and Report Highlights 1 Malaria Burden 2 Key activities undertaken in First
More informationNATIONAL TUBERCULOSIS CONTROL PROGRAMME- SCC AREA Quarterly Report on New and Retreatment Cases of Tuberculosis
NATIONAL TUBERCULOSIS CONTROL PROGRAMME- SCC AREA Quarterly Report on New and Retreatment Cases of Tuberculosis Patients registered during quarter* of 20 Name of area No.# Name of the Reporter Signature:
More informationTB Control activities and Success factors and Challenges for monitoring and Evaluation of the Mangement of LTBI in Cambodia
TB Control activities and Success factors and Challenges for monitoring and Evaluation of the Mangement of LTBI in Cambodia Global Consultation on Programmatic Management of LTBI 27-28 /04/ 2016 Seoul,
More informationANALYSIS AND USE OF HEALTH FACILITY DATA. Guidance for tuberculosis programme managers
ANALYSIS AND USE OF HEALTH FACILITY DATA Guidance for tuberculosis programme managers WORKING DOCUMENT SEPTEMBER 2018 World Health Organization 2018 All rights reserved. This is a working document and
More informationOpen Access Article pissn eissn
Original article ASSESSMENT OF LONG-TERM OUTCOME AMONG NEW SMEAR POSITIVE PULMONARY TB PATIENTS TREATED WITH INTERMITTENT REGIMEN UNDER RNTCP A RETROSPECTIVE COHORT STUDY Paresh Dave 1, Kiran Rade 2, Bhavesh
More informationFinding the missing TB cases
Finding the missing TB cases Optimizing strategies to enhance case detection in high HIV burden settings Dr Malgosia Grzemska Global TB Programme, WHO/HQ, Geneva SWITZERLAND Child and Adolescent TB Working
More information10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan,
10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan, 2006 2015 Introduction A significant scaling-up of advocacy, communication and social mobilization for TB will
More informationTuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012
Tuberculosis New TB diagnostics. New drugs.new vaccines Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis (TB )is a bacterial disease caused by Mycobacterium tuberculosis (occasionally
More informationTB Control in Finland - the role of THL
TB Control in Finland - the role of THL Hanna Soini THL, Department of Health Security 1 TB in Finland 1950-2014 12000 10000 8000 6000 TB ulkomaalaiset TB yhteensä 4000 2000 0 1950 1955 1960 1965 1970
More informationREGIONAL COMMITTEE FOR AFRICA AFR/RC53/13 Rev June 2003 Fifty-third session Johannesburg, South Africa, 1 5 September 2003
WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR AFRICA ORGANISATION MONDIALE DE LA SANTE BUREAU REGIONAL DE L AFRIQUE ORGANIZAÇÃO MUNDIAL DE SAÚDE ESCRITÓRIO REGIONAL AFRICANO REGIONAL COMMITTEE FOR AFRICA
More information